NCI Funding New IMAT Grants | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute has issued three new grant opportunities funding emerging cancer technologies through its Innovative Molecular Analysis Technologies Program (IMAT).

The aim of the IMAT program is to fund research that generates tools and methods that enable cancer researchers to develop new tools for detecting, diagnosing, and treating cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.